T-Cell Response in a Cardiac Xenotransplant Model

Exp Clin Transplant. 2021 Jul;19(7):708-716. doi: 10.6002/ect.2020.0359. Epub 2021 Jun 3.

Abstract

Objectives: Despite the advances in preclinical cardiac xenotransplantation, the immune reactions caused by species differences are not fully understood. Hyperacute rejection can now be avoided using genetically engineered donor organs, but cellmediated rejection by the adaptive immune response has not been addressed successfully. Here we investigated the initial human pan-T-cell reaction using a pig-human blood working heart model.

Materials and methods: Porcine wild-type hearts (n = 7) were perfused with human blood in a biventricular working heart system for 3 hours. As control, blood from the same human donors was circulated without a pig heart. Pan-T cells were selectively extracted from blood taken before and at the end of the perfusion cycle. The relative mRNA expression of selected target genes (real-time quantitative polymerase chain reaction) and the expression of microRNAs were determined.

Results: After xenogeneic organ perfusion, there was a moderate upregulation of several CD4+ marker cytokines (interleukin 2, interleukin 4, interferon γ) compared with control. We found a distinct increase in the mRNA expression of granzyme B and perforin, key markers of cytotoxic T cells. No differences in the marker genes of regulatory T cells were evident. Levels of the anti-inflammatory microRNAs miR-16 and miR-93 were significantly higher in the xenoperfused group than in the control group.

Conclusions: This study demonstrated that contact of human blood with pig endothelium activates cytotoxic T cells within the first few hours, indicating acute rejection processes. This is accompanied by upregulation of anti-inflammatory microRNAs, which may represent compensatory anti-inflammatory mechanisms.

MeSH terms

  • Animals
  • Graft Rejection / genetics
  • Graft Rejection / prevention & control
  • Heart Transplantation* / adverse effects
  • Heterografts
  • Humans
  • MicroRNAs* / genetics
  • RNA, Messenger
  • Swine
  • Transplantation, Heterologous
  • Treatment Outcome

Substances

  • MicroRNAs
  • RNA, Messenger